Combination Therapy for Rheumatoid Arthritis in the Era of Biologicals
Identifieur interne : 001D56 ( Main/Exploration ); précédent : 001D55; suivant : 001D57Combination Therapy for Rheumatoid Arthritis in the Era of Biologicals
Auteurs : Allan Gibofsky [États-Unis]Source :
- HSS Journal [ 1556-3316 ] ; 2006-02-01.
English descriptors
- KwdEn :
Abstract
Abstract: Early, aggressive disease management is critical for halting disease progression and joint destruction in patients with rheumatoid arthritis. Combination therapy with at least two disease-modifying antirheumatic drugs, such as methotrexate (MTX), sulfasalazine, or hydroxychloroquine, is often more effective than monotherapy in reducing disease activity. Biologic therapies represent more effective and tolerable treatment options that, when combined with MTX, have been shown to dramatically reduce inflammation, inhibit radiographic progression, and induce remission. Although several types of treatment strategies are used in clinical practice, the most aggressive approaches that target early disease have shown the most promise in reversing disease progression and reducing disease-related costs.
Url:
DOI: 10.1007/s11420-005-0133-z
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000211
- to stream Istex, to step Curation: 000211
- to stream Istex, to step Checkpoint: 000C24
- to stream Main, to step Merge: 001D68
- to stream Main, to step Curation: 001D56
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Combination Therapy for Rheumatoid Arthritis in the Era of Biologicals</title><author><name sortKey="Gibofsky, Allan" sort="Gibofsky, Allan" uniqKey="Gibofsky A" first="Allan" last="Gibofsky">Allan Gibofsky</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:40DFC78C74C576B9FA1303CC510E6E0E51BEE582</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1007/s11420-005-0133-z</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-5G7XCT18-4/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000211</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000211</idno><idno type="wicri:Area/Istex/Curation">000211</idno><idno type="wicri:Area/Istex/Checkpoint">000C24</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000C24</idno><idno type="wicri:doubleKey">1556-3316:2006:Gibofsky A:combination:therapy:for</idno><idno type="wicri:Area/Main/Merge">001D68</idno><idno type="wicri:Area/Main/Curation">001D56</idno><idno type="wicri:Area/Main/Exploration">001D56</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Combination Therapy for Rheumatoid Arthritis in the Era of Biologicals</title><author><name sortKey="Gibofsky, Allan" sort="Gibofsky, Allan" uniqKey="Gibofsky A" first="Allan" last="Gibofsky">Allan Gibofsky</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Departments of Medicine and Public Health, Weill Medical College of Cornell University, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Hospital for Special Surgery, 535 East 70th Street, 10021, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation><affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country></affiliation></author></analytic><monogr></monogr><series><title level="j">HSS Journal</title><title level="j" type="sub">The Musculoskeletal Journal of Hospital for Special Surgery</title><title level="j" type="abbrev">HSS Jrnl</title><idno type="ISSN">1556-3316</idno><idno type="eISSN">1556-3324</idno><imprint><publisher>Springer-Verlag; http://www.springer-ny.com</publisher><pubPlace>New York</pubPlace><date type="published" when="2006-02-01">2006-02-01</date><biblScope unit="volume">2</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="30">30</biblScope><biblScope unit="page" to="41">41</biblScope></imprint><idno type="ISSN">1556-3316</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1556-3316</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>combination therapy</term><term>disease-modifying antirheumatic drugs</term><term>joint destruction</term><term>rheumatoid arthritis</term><term>tumor necrosis factor antagonists</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Early, aggressive disease management is critical for halting disease progression and joint destruction in patients with rheumatoid arthritis. Combination therapy with at least two disease-modifying antirheumatic drugs, such as methotrexate (MTX), sulfasalazine, or hydroxychloroquine, is often more effective than monotherapy in reducing disease activity. Biologic therapies represent more effective and tolerable treatment options that, when combined with MTX, have been shown to dramatically reduce inflammation, inhibit radiographic progression, and induce remission. Although several types of treatment strategies are used in clinical practice, the most aggressive approaches that target early disease have shown the most promise in reversing disease progression and reducing disease-related costs.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>État de New York</li></region></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Gibofsky, Allan" sort="Gibofsky, Allan" uniqKey="Gibofsky A" first="Allan" last="Gibofsky">Allan Gibofsky</name></region><name sortKey="Gibofsky, Allan" sort="Gibofsky, Allan" uniqKey="Gibofsky A" first="Allan" last="Gibofsky">Allan Gibofsky</name><name sortKey="Gibofsky, Allan" sort="Gibofsky, Allan" uniqKey="Gibofsky A" first="Allan" last="Gibofsky">Allan Gibofsky</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D56 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001D56 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:40DFC78C74C576B9FA1303CC510E6E0E51BEE582
|texte= Combination Therapy for Rheumatoid Arthritis in the Era of Biologicals
}}
| This area was generated with Dilib version V0.6.33. |  |